$ICPT You guys wanted a link to OCA, here ya go: “Chronic elevation of plasma fibroblast growth factor 19 in long‐term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern? ”2018 - Hepatology - Wiley Online Library That was an editorial in Hepatology in 2018. In 2019 close to 100 articles were published (as per PubMed) linking FGF19 with cancer, culminating in a Dec 2019 paper that flat out called FGF19 an oncogenic driver for HCC Yesterday, the first drug targeting the FGF/FGFR axis as a treatment for cancer was approved by the EU I advise you to read that 2018 Hepatology editorial and see where the literature has progressed over the last year Not a broken record as I have included new material here ( that Hepatology Editorial on FXRS and FGF19) OCA is an FXR - in case you didn’t know
  • 3